Senate bill targets generic drug delay tactic


By Adam Lidgett (Oct 5, 2021, 6:02 p.m. EDT) – A bipartisan duo of senators are proposing legislation to prevent manufacturers of generic drugs with exclusive rights from blocking other generics for extended periods of time.

The Law on Expanding Access to Low-Cost Generics would attempt to curb a practice called “parking” exclusivity, a problem that has existed for years.

The first applicant for a generic drug benefits from a 180-day exclusivity as a financial incentive.

But by delaying obtaining final approval, the applicant can avoid the loss of exclusivity triggered by the non-marketing of an approved drug. Generic drug makers sometimes agree to postpone sales because …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific case articles and topics and more!

TRY LAW360 FREE FOR SEVEN DAYS


Source link

Previous Best Squid Game Theories For Season 2: What Happened To Ali?
Next Why you need to build big and strong calf muscles

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *